Drawing for SPECTRUM PLASTICS GROUP

USPTO serial 99557511

SPECTRUM PLASTICS GROUP

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
KENNEDY, LAURA E
Law office
TMO LAW OFFICE 130

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with SPECTRUM PLASTICS GROUP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher Casavale

Christopher Casavale NELSON MULLINS RILEY & SCARBOROUGH LLP301 South College St, Suite 2300Charlotte, NC 28202United States

Goods and services

ClassDescriptionStatusFirst use
010Surgical devices and instruments; disposable medical sterilization pouches; catheters and parts and fittings therefor; medical tubing for drainage, transfusion, administering drugs; medical apparatus, namely, implantable ports; implants consisting of artificial materials; biodegradable bone fixation implants; implants comprising natural, non-living materials; surgical implants comprising artificial material and associated surgical instrument sets; surgical implants comprising artificial material; fixation implants comprised of artificial material; orthopedic joint implants made of artificial materials; medical, surgical and orthopedic implants made of artificial materials; implants consisting primarily of artificial materials and also including biological materials; medical devices, namely, intravascular implants comprised of artificial material; medical implants of artificial material in particular for anchoring joint capsule components and ligament tendon structures; medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery; surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; medical and surgical apparatus and instruments, namely, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs; medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; thermoplastic implantable and bioresorbable components, namely, suture anchors and screws, fasteners, staples, and ties, microvascular anastomosis devices, bone and tissue scaffolding; Luer lock tapers and needles for medical use; single-use one, two, and three port medical bags for the preparation, storage and transport of fluids and biopharmaceutical solutions; intravenous bags sold empty for intravenous therapy; bags for the collection and disposal of emesis waste, blood storage and collection bags for medical purposes; medical specimen bags for holding body tissue samples for testing purposes; cannulae; tubing for use with cannulas; enteral feeding pumps; tubes for enteral feeding; clamps for surgical use; vented and non-vented chambers and chamber assemblies for fluid administration, namely, Burette chambers, IV drip chambers, micro drip chambers, UV blocking chambers; subcutaneous valves comprised of artificial materials for implantationACTIVEDec 31, 2017
016plastic film roll stock for packaging pharmaceuticalsACTIVEDec 31, 2017
017flexible plastic and silicone tubing used for transport of liquids and biologicals for use in the pharmaceutical and medical industriesACTIVEDec 31, 2017
035Regulatory submission management, namely, assisting others in preparing and filing applications and reports for medical devices with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approvalACTIVEDec 31, 2017
039Warehousing servicesACTIVEDec 31, 2017
040Custom manufacturing of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical marketsACTIVEDec 31, 2017
042New product design services; product development; tool design, tool management systems design services; providing quality assurance services in the field of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical markets; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical marketsACTIVEDec 31, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Oct 27, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 27, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 27, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2026DOCKASSIGNED TO EXAMINER—
Feb 3, 2026TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Feb 3, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance